Literature DB >> 22949502

A novel mechanism for the autonomous termination of pre-B cell receptor expression via induction of lysosome-associated protein transmembrane 5.

Yohei Kawano1, Rika Ouchida, Ji-Yang Wang, Soichiro Yoshikawa, Mutsumi Yamamoto, Daisuke Kitamura, Hajime Karasuyama.   

Abstract

The expression of the pre-B cell receptor (BCR) is confined to the early stage of B cell development, and its dysregulation is associated with anomalies of B-lineage cells, including leukemogenesis. Previous studies suggested that the pre-BCR signal might trigger the autonomous termination of pre-BCR expression even before the silencing of pre-BCR gene expression to prevent sustained pre-BCR expression. However, the underlying mechanism remains ill defined. Here we demonstrate that the pre-BCR signal induces the expression of lysosome-associated protein transmembrane 5 (LAPTM5), which leads to the prompt downmodulation of the pre-BCR. While LAPTM5 induction had no significant impact on the internalization of cell surface pre-BCR, it elicited the translocation of a large pool of intracellular pre-BCR from the endoplasmic reticulum to the lysosomal compartment concomitantly with a drastic reduction of the level of intracellular pre-BCR proteins. This reduction was inhibited by lysosomal inhibitors, indicating the lysosomal degradation of the pre-BCR. Notably, the LAPTM5 deficiency in pre-B cells led to the augmented expression level of surface pre-BCR. Collectively, the pre-BCR induces the prompt downmodulation of its own expression through the induction of LAPTM5, which promotes the lysosomal transport and degradation of the intracellular pre-BCR pool and, hence, limits the supply of pre-BCR to the cell surface.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949502      PMCID: PMC3486144          DOI: 10.1128/MCB.00531-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Pre-B cell receptor assesses the quality of IgH chains and tunes the pre-B cell repertoire by delivering differential signals.

Authors:  Yohei Kawano; Soichiro Yoshikawa; Yoshiyuki Minegishi; Hajime Karasuyama
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

2.  Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor.

Authors:  Sonja Meixlsperger; Fabian Köhler; Thomas Wossning; Michael Reppel; Markus Müschen; Hassan Jumaa
Journal:  Immunity       Date:  2007-03-01       Impact factor: 31.745

3.  BASH-novel PKC-Raf-1 pathway of pre-BCR signaling induces kappa gene rearrangement.

Authors:  Mutsumi Yamamoto; Katsuhiko Hayashi; Takuya Nojima; Yumi Matsuzaki; Yohei Kawano; Hajime Karasuyama; Ryo Goitsuka; Daisuke Kitamura
Journal:  Blood       Date:  2006-06-22       Impact factor: 22.113

4.  Maintenance of surrogate light chain expression induces developmental delay in early B cell compartment.

Authors:  Denise A Martin; Liwei Lu; Marilia Cascalho; Gillian E Wu
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

5.  Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.

Authors:  Pieter Fokko van Loo; Gemma M Dingjan; Alex Maas; Rudi W Hendriks
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

6.  A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae.

Authors:  D L Hogue; L Kerby; V Ling
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

7.  Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes.

Authors:  M A Cabrita; T C Hobman; D L Hogue; K M King; C E Cass
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

8.  Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.

Authors:  Shibin Ma; Simanta Pathak; Long Trinh; Runqing Lu
Journal:  Blood       Date:  2007-10-30       Impact factor: 22.113

9.  Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination.

Authors:  Youngshil Pak; Wioletta K Glowacka; M Christine Bruce; Nam Pham; Daniela Rotin
Journal:  J Cell Biol       Date:  2006-11-20       Impact factor: 10.539

10.  Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits.

Authors:  Elizabeth C Thompson; Bradley S Cobb; Pierangela Sabbattini; Sonja Meixlsperger; Vania Parelho; David Liberg; Benjamin Taylor; Niall Dillon; Katia Georgopoulos; Hassan Jumaa; Stephen T Smale; Amanda G Fisher; Matthias Merkenschlager
Journal:  Immunity       Date:  2007-03       Impact factor: 31.745

View more
  8 in total

1.  LAPTM5 mediates immature B cell apoptosis and B cell tolerance by regulating the WWP2-PTEN-AKT pathway.

Authors:  Ying Wang; Jun Liu; Chizuru Akatsu; Runyun Zhang; Hai Zhang; Han Zhu; Kangwei Liu; Han-Ying Zhu; Qing Min; Xin Meng; Chaoqun Cui; Yue Tang; Meiping Yu; Yaxuan Li; Xiaoqian Feng; Hao Wei; Zichao Wen; Sihan Ji; Martin G Weigert; Takeshi Tsubata; Ji-Yang Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

2.  The endoplasmic reticulum-resident E3 ubiquitin ligase Hrd1 controls a critical checkpoint in B cell development in mice.

Authors:  Yi Yang; Sinyi Kong; Yana Zhang; Johanna Melo-Cardenas; Beixue Gao; Yusi Zhang; Donna D Zhang; Bin Zhang; Jianxun Song; Edward Thorp; Kezhong Zhang; Jinping Zhang; Deyu Fang
Journal:  J Biol Chem       Date:  2018-06-15       Impact factor: 5.157

3.  Combined Identification of Novel Markers for Diagnosis and Prognostic of Classic Hodgkin Lymphoma.

Authors:  Zhixing Kuang; Jiannan Tu; Xun Li
Journal:  Int J Gen Med       Date:  2021-12-18

4.  Down-regulation of LAPTM5 in human cancer cells.

Authors:  Michelle Nuylan; Tatsuyuki Kawano; Johji Inazawa; Jun Inoue
Journal:  Oncotarget       Date:  2016-05-10

5.  Integrative Informatics Analysis of Transcriptome and Identification of Interacted Genes in the Glomeruli and Tubules in CKD.

Authors:  Lingyun Liu; Fuzhe Ma; Yuanyuan Hao; Zhengzi Yi; Xiaoxia Yu; Bo Xu; Chengguo Wei; Jinghai Hu
Journal:  Front Med (Lausanne)       Date:  2021-02-12

6.  The Ig heavy chain protein but not its message controls early B cell development.

Authors:  Muhammad Assad Aslam; Mir Farshid Alemdehy; Bingtao Hao; Peter H L Krijger; Colin E J Pritchard; Iris de Rink; Fitriari Izzatunnisa Muhaimin; Ika Nurzijah; Martijn van Baalen; Ron M Kerkhoven; Paul C M van den Berk; Jane A Skok; Heinz Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

7.  Key Prognostic Value of Lysosomal Protein Transmembrane 5 in Kidney Renal Clear Cell Carcinoma.

Authors:  Bin Li; Xue-Dong Shi
Journal:  Int J Gen Med       Date:  2022-03-05

8.  LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells.

Authors:  Yuan-Ming Geng; Cheng-Xia Liu; Wei-Ying Lu; Ping Liu; Pei-Yan Yuan; Wei-Long Liu; Ping-Ping Xu; Xiao-Qing Shen
Journal:  Mol Med Rep       Date:  2019-09-16       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.